BNGO - Bionano Genomics Forward P/E Multiple

Graphic logo of Bionano Genomics, Inc. (BNGO)

Bionano Genomics, Inc. (BNGO) is facing a severe liquidity shortage as expansion costs outpace revenues. Meanwhile, the company is implementing energy-efficient IT solutions and strictly adhering to data privacy. The company's forward P/E ratio visualizes the current market valuation, where the 0.00 parameter determines the metric's magnitude. Fundamental DNA analysis patents create a powerful barrier to entry for competitors.

Price to Future Earnings Ratio: bionanogenomics.com (BNGO) for 07/04/2022 - 11/17/2026

Financial and market metric breakdowns for Bionano Genomics, Inc. (BNGO)

- stock value and consensus price forecast:
- market capitalization statistics:
Initial company analysis:Bionano Genomics
Product sample of Bionano

The forward P/E reflects the ratio of market capitalization to projected net income, allowing investors to filter out market noise and assess the asset's fundamental value. By analyzing the forward price-to-earnings multiple of Bionano Genomics, Inc. (BNGO), an investor determines the premium paid for future growth, which is critical when scaling Saphyr automated systems and implementing AI-driven DNA analysis to minimize operational errors.

Competitors of Bionano Genomics, Inc. (BNGO)

Projected Price to Earnings TEM (Tempus AI, Inc)|Qiagen Group (QGEN) - Forward Price to Earnings Multiple|Future Price to Earnings ionispharma.com IONS|Market Cap to Projected Earnings Repligen Corporation (RGEN)|RNA: Projected Price to Earnings|Future Price to Earnings Multiple CRSP (CRISPR Therapeutics Corp)|WGS: Forward P/E Multiple|Projected Price to Earnings Ratio Ultragenyx Corp (RARE)|BEAM (Beam Therapeutics Inc) - Forward P/E Multiple|SRPT: Future Price to Earnings Multiple|Future Price to Earnings Twist Bioscience Corp (TWST)|Projected Price to Earnings 10x Genomics Inc TXG|Intellia Therapeutics, Inc. - Projected Price to Earnings|Future Price to Earnings Multiple STOK|BLFS - Future Price to Earnings|Wave Life Sciences (WVE) - Projected Price to Earnings|MAZE: Forward P/E Multiple|Sionna Therapeutics, Inc. (SION) - Forward P/E Multiple|Future Price to Earnings Prime Medicine, Inc.|TSHA (Taysha) - Market Cap to Future Earnings Ratio|Projected Price to Earnings QURE (uniQure Pharma)|Market Cap to Projected Earnings meiragtx.com|Future Price to Earnings REGENXBIO RGNX|SLDB - Projected Price to Earnings|Ocugen, Inc. - Forward P/E Multiple|PACB (Pacific Biosciences of California) - Price to Future Earnings Ratio|BNTC: Forward P/E Multiple|DSGN - Market Cap to Projected Earnings|RCKT (Rocket Pharma) - Forward P/E Multiple|Future Price to Earnings FDMT|Future Price to Earnings Lexeo Therapeutics, Inc. (LXEO)|Korro Bio Inc. - Price to Future Earnings Ratio|editasmedicine.com - Projected Price to Earnings|Market Cap to Projected Earnings silence-therapeutics.com (SLN)|PRQR: Projected Price to Earnings|Projected Price to Earnings Ratio codexis.com|SGMO: Forward P/E Multiple|Projected Price to Earnings Ratio Nautilus Biotechnology Inc (NAUT)|Projected Price to Earnings MGX|DTIL (Precision BioSciences) - Market Cap to Future Earnings Ratio|Future Price to Earnings Generation Bio Corp (GBIO)|Boundless Bio - Price to Future Earnings Ratio|Future Price to Earnings Exicure, Inc. XCUR|Future Price to Earnings Multiple IMNN|PHIO - Future Price to Earnings|Market Cap to Projected Earnings Mustang Bio Inc MBIO|RNAZ: Forward P/E Multiple|Applied DNA Sciences, Inc. (APDN) - Forward P/E Multiple|BLUE (bluebirdbio.com) - Forward P/E Multiple|Price to Future Earnings Ratio IPA (ImmunoPrecise Antibodies)|Forward P/E Multiple OMGA|Projected Price to Earnings Singular Genomics Systems OMIC|Forward P/E Multiple RGLS (regulusrx.com)|Syros Pharmaceuticals Inc. (SYRS) - Projected Price to Earnings Ratio|TBIO: Projected Price to Earnings|Future Price to Earnings Multiple TCON (TRACON)|UBX: Forward P/E Multiple